RaySearch Laboratories AB (publ) (RAY-B.ST)
SEK 205.0
(1.49%)
SEK 205.0
(1.49%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 2.38 SEK | 244.93% |
| 2022 | 0.69 SEK | 150.0% |
| 2021 | -1.38 SEK | -430.77% |
| 2020 | -0.26 SEK | -117.69% |
| 2019 | 1.47 SEK | -35.81% |
| 2018 | 2.29 SEK | -33.24% |
| 2017 | 3.43 SEK | -22.4% |
| 2016 | 4.42 SEK | 115.61% |
| 2015 | 2.05 SEK | 17.14% |
| 2014 | 1.75 SEK | 386.89% |
| 2013 | -0.61 SEK | -205.17% |
| 2012 | 0.58 SEK | 16.0% |
| 2011 | 0.50 SEK | -40.48% |
| 2010 | 0.84 SEK | -4.55% |
| 2009 | 0.88 SEK | 66.04% |
| 2008 | 0.53 SEK | -8.62% |
| 2007 | 0.58 SEK | -45.28% |
| 2006 | 1.06 SEK | 24.71% |
| 2005 | 0.85 SEK | 107.32% |
| 2004 | 0.41 SEK | 220.59% |
| 2003 | -0.34 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 1.79 SEK | 67.29% |
| 2024 Q1 | 1.07 SEK | 16.3% |
| 2023 FY | - SEK | 244.93% |
| 2023 Q3 | 0.63 SEK | 96.88% |
| 2023 Q2 | 0.32 SEK | -37.25% |
| 2023 Q1 | 0.51 SEK | 24.39% |
| 2023 Q4 | 0.92 SEK | 46.03% |
| 2022 Q4 | 0.41 SEK | 41.38% |
| 2022 Q2 | -0.58 SEK | -203.57% |
| 2022 Q1 | 0.56 SEK | 219.15% |
| 2022 FY | - SEK | 150.0% |
| 2022 Q3 | 0.29 SEK | 150.0% |
| 2021 Q3 | -0.64 SEK | -33.33% |
| 2021 FY | - SEK | -430.77% |
| 2021 Q1 | 0.21 SEK | 151.22% |
| 2021 Q4 | -0.47 SEK | 26.56% |
| 2021 Q2 | -0.48 SEK | -328.57% |
| 2020 Q2 | -0.27 SEK | -122.88% |
| 2020 Q1 | 1.18 SEK | 114.55% |
| 2020 Q4 | -0.41 SEK | 46.05% |
| 2020 FY | - SEK | -117.69% |
| 2020 Q3 | -0.76 SEK | -181.48% |
| 2019 Q3 | -0.22 SEK | -134.38% |
| 2019 Q2 | 0.64 SEK | 28.0% |
| 2019 Q4 | 0.55 SEK | 350.0% |
| 2019 FY | - SEK | -35.81% |
| 2019 Q1 | 0.50 SEK | -47.37% |
| 2018 FY | - SEK | -33.24% |
| 2018 Q4 | 0.95 SEK | 143.59% |
| 2018 Q3 | 0.39 SEK | -35.0% |
| 2018 Q2 | 0.60 SEK | 76.47% |
| 2018 Q1 | 0.34 SEK | -83.89% |
| 2017 FY | - SEK | -22.4% |
| 2017 Q1 | 0.77 SEK | -65.16% |
| 2017 Q3 | -0.03 SEK | -105.08% |
| 2017 Q2 | 0.59 SEK | -23.38% |
| 2017 Q4 | 2.11 SEK | 7133.33% |
| 2016 Q1 | 0.52 SEK | -46.39% |
| 2016 FY | - SEK | 115.61% |
| 2016 Q2 | 0.84 SEK | 61.54% |
| 2016 Q3 | 0.84 SEK | 0.0% |
| 2016 Q4 | 2.21 SEK | 163.1% |
| 2015 FY | - SEK | 17.14% |
| 2015 Q3 | 0.42 SEK | 625.0% |
| 2015 Q4 | 0.97 SEK | 130.95% |
| 2015 Q2 | -0.08 SEK | -110.96% |
| 2015 Q1 | 0.73 SEK | -39.17% |
| 2014 Q2 | - SEK | -100.0% |
| 2014 FY | - SEK | 386.89% |
| 2014 Q4 | 1.20 SEK | 207.69% |
| 2014 Q3 | 0.39 SEK | 0.0% |
| 2014 Q1 | 0.17 SEK | 13.33% |
| 2013 Q4 | 0.15 SEK | 134.09% |
| 2013 FY | - SEK | -205.17% |
| 2013 Q3 | -0.44 SEK | 6.38% |
| 2013 Q2 | -0.47 SEK | -413.33% |
| 2013 Q1 | 0.15 SEK | -79.73% |
| 2012 Q1 | 0.13 SEK | -35.0% |
| 2012 Q3 | -0.04 SEK | 84.0% |
| 2012 Q2 | -0.25 SEK | -292.31% |
| 2012 FY | - SEK | 16.0% |
| 2012 Q4 | 0.74 SEK | 1950.0% |
| 2011 Q2 | -0.01 SEK | -119.4% |
| 2011 Q3 | 0.26 SEK | 2780.41% |
| 2011 Q4 | 0.20 SEK | -23.08% |
| 2011 FY | - SEK | -40.48% |
| 2011 Q1 | 0.05 SEK | -84.85% |
| 2010 Q4 | 0.33 SEK | 3200.0% |
| 2010 FY | - SEK | -4.55% |
| 2010 Q3 | 0.01 SEK | -96.3% |
| 2010 Q2 | 0.27 SEK | 12.5% |
| 2010 Q1 | 0.24 SEK | -52.94% |
| 2009 Q1 | 0.21 SEK | 0.0% |
| 2009 Q3 | 0.01 SEK | -93.33% |
| 2009 FY | - SEK | 66.04% |
| 2009 Q4 | 0.51 SEK | 5000.0% |
| 2009 Q2 | 0.15 SEK | -28.57% |
| 2008 FY | - SEK | -8.62% |
| 2007 FY | - SEK | -45.28% |
| 2006 FY | - SEK | 24.71% |
| 2005 FY | - SEK | 107.32% |
| 2004 FY | - SEK | 220.59% |
| 2003 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aino Health AB (publ) | -0.08 SEK | 2906.604% |
| Bonzun AB (publ) | 0.11 SEK | -2063.636% |
| Kontigo Care AB (publ) | 0.01 SEK | -26945.455% |
| Medhelp Care Aktiebolag (publ) | -0.36 SEK | 761.111% |
| Surgical Science Sweden AB (publ) | 4.59 SEK | 48.148% |